title: [Fetal toxicity of angiotensin-II receptor antagonists].
abstract: We report a case of a newborn with an oligohydramnios, acute renal failure and ossification abnormalities. The role of maternal treatment of essential hypertension by angiotensin-II receptor antagonists is discussed in regard to the literature and pathophysiological data.
authors.affiliation: Service de Réanimation Pédiatrique et Néonatale, Hôpital Gatien-de-Clocheville, 49, boulevard Béranger, 37000 Tours.
authors.forename: V
authors.initials: V
authors.lastname: Payen
authors.forename: A
authors.initials: A
authors.lastname: Chemin
authors.forename: A-P
authors.initials: AP
authors.lastname: Jonville-Béra
authors.forename: E
authors.initials: E
authors.lastname: Saliba
authors.forename: S
authors.initials: S
authors.lastname: Cantagrel
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D001713:Biphenyl Compounds; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D016104:Oligohydramnios / Q000139:chemically induced*; D011247:Pregnancy; D013777:Tetrazoles / Q000009:adverse effects*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan